NUVIG THERAPEUTICS

Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inﬂammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.

#People #Financial #Event #More

NUVIG THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Therapeutics

Address:

Redwood City, California, United States

Country:

United States

Total Employee:

1+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

47 M USD

Current Employees Featured

joanne-quan_image

Joanne Quan
Joanne Quan Chief Medical Officer @ Nuvig Therapeutics
Chief Medical Officer
2022-01-01

Investors List

bristol-myers-squibb_image

Bristol Myers Squibb

Bristol Myers Squibb investment in Series A - Nuvig Therapeutics

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Series A - Nuvig Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Nuvig Therapeutics

digitalis-ventures_image

Digitalis Ventures

Digitalis Ventures investment in Series A - Nuvig Therapeutics

Key Employee Changes

Date	New article
2022-08-15	Nuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer

More informations about "Nuvig Therapeutics" on Search Engine